Lane now provides you access to the STAT+. Use your Stanford affiliated email to create an account for full access to STAT+ content.
Use STAT+ to Receive Current News in Biotech and Pharma
After creating your STAT+ account, you will have access to:
- Daily reporting and analysis of the biotech, pharma, and health tech industries
- Subscriber-only newsletters to brief you on scientific and policy developments from the NIH, FDA, and Congress as well as clinical trial results
- Customizable daily feeds
- Webinars and conversations with medical and industry leaders
The platform also includes a “Coronavirus” section, curating the latest coverage on the spread of the virus as well as treatment and vaccine development.